Liked the increased level of technical info being shared. Most of us are not geologists but we collectively pay geologists a lot of money to work on our behalf and deserve to know exactly what they are doing, the processes underway and what it takes to get the big picture of what's happening underground. The bigger picture is a little clearer now, especially at Cancet.
I like this update. Everything is looking good for Christmas.
We didn't have any geologists on the team before, so management probably didn't really have a clear enough understanding of the best path forward at Cancet. That's why they stopped IMO, they froze with uncertainty and didn't know what to do next. This 2 - 3 week field program should bring a lot of data in for analysis and future target generation. Guess it will take another month or two after completion before this data and any conclusions drawn from it are presented to us for our own analysis, which is appropriate, but any longer will be pushing the envelope. This work is paid for by us all, collectively, we own it.
With regards to future funding, we have to earn it. Not gonna get it if we don't deserve it. What have we got worth selling yet,? Just the dream which we all bought already. There's a reason banks don't fund exploration, it's risky because you don't even know if there is an asset there to back it yet.
A cap raise after good results from cobalt drilling, where we are the biggest landholders of prospective cobalt ground in the Cobalt region and detailed information with an updated model from Cancet should be our goal now IMO. Best logical way forward. Or if we can get a good deal for a JV at Cancet after an updated model of course, but looks like we're ready to wash our hands of Adina to me.
- Forums
- ASX - By Stock
- MTC
- Ann: MTC Canadian Cobalt and Lithium Projects Exploration Update
MTC
metalstech limited
Add to My Watchlist
3.85%
!
13.5¢

Ann: MTC Canadian Cobalt and Lithium Projects Exploration Update, page-10
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
13.5¢ |
Change
0.005(3.85%) |
Mkt cap ! $28.17M |
Open | High | Low | Value | Volume |
13.5¢ | 13.5¢ | 13.5¢ | $3.713K | 27.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 67188 | 13.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
13.5¢ | 1000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 67188 | 0.130 |
4 | 44619 | 0.125 |
3 | 138341 | 0.120 |
1 | 10000 | 0.100 |
1 | 10500 | 0.094 |
Price($) | Vol. | No. |
---|---|---|
0.135 | 1000 | 1 |
0.140 | 18675 | 2 |
0.145 | 126965 | 4 |
0.150 | 50000 | 1 |
0.155 | 35745 | 1 |
Last trade - 14.10pm 27/06/2025 (20 minute delay) ? |
Featured News
MTC (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online